Skip to main content

Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma.

Publication ,  Journal Article
Khalid, B; Mukherjee, S; Ibrahimi, S; Cannon, T; Gilles, E; Moreau, A; Razaq, M
Published in: Am J Ther
2018

Duke Scholars

Published In

Am J Ther

DOI

EISSN

1536-3686

Publication Date

2018

Volume

25

Issue

3

Start / End Page

e394 / e396

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Smoothened Receptor
  • Skin Neoplasms
  • Pyridines
  • Middle Aged
  • Male
  • Humans
  • Cardiovascular System & Hematology
  • Carcinoma, Basal Cell
  • Biphenyl Compounds
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Khalid, B., Mukherjee, S., Ibrahimi, S., Cannon, T., Gilles, E., Moreau, A., & Razaq, M. (2018). Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma. Am J Ther, 25(3), e394–e396. https://doi.org/10.1097/MJT.0000000000000721
Khalid, Bilal, Sarbajit Mukherjee, Sami Ibrahimi, Trinitia Cannon, Elizabeth Gilles, Annie Moreau, and Mohammad Razaq. “Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma.Am J Ther 25, no. 3 (2018): e394–96. https://doi.org/10.1097/MJT.0000000000000721.
Khalid B, Mukherjee S, Ibrahimi S, Cannon T, Gilles E, Moreau A, et al. Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma. Am J Ther. 2018;25(3):e394–6.
Khalid, Bilal, et al. “Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma.Am J Ther, vol. 25, no. 3, 2018, pp. e394–96. Pubmed, doi:10.1097/MJT.0000000000000721.
Khalid B, Mukherjee S, Ibrahimi S, Cannon T, Gilles E, Moreau A, Razaq M. Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma. Am J Ther. 2018;25(3):e394–e396.

Published In

Am J Ther

DOI

EISSN

1536-3686

Publication Date

2018

Volume

25

Issue

3

Start / End Page

e394 / e396

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Smoothened Receptor
  • Skin Neoplasms
  • Pyridines
  • Middle Aged
  • Male
  • Humans
  • Cardiovascular System & Hematology
  • Carcinoma, Basal Cell
  • Biphenyl Compounds